← Leaderboards
David Richard Myers
Emory University
$6,395,874
Attributed
$9,440,293
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,440,293 · 8
By mechanism
R01$7,401,204 · 4
R21$1,142,960 · 2
K25$787,745 · 1
T32$108,384 · 1
Top collaborators
- Brooks D Lindsey3 shared
- Matthew Collins2 shared
- Wilbur A Lam1 shared
- Razieh Nabi1 shared
- Francisco E Robles1 shared
- Jesse Waggoner1 shared
Most similar at Emory University
Same institution · by research overlap
- Oluwamayokun Oshinowo$155,482
- Wilbur A Lam$39,688,140
- Matthew Collins$2,679,353
- Cheryl Maier$1,473,950
- Frances Eun-Hyung Lee$16,287,959
Others in their field
Other Emerging Leaders on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- Lynn Briscoe · Leidos Biomedical Research, Inc.$100,239,656
- Leonard Freedmand · Leidos Biomedical Research, Inc.$63,918,621
- Mark Marino · Venturewell$61,502,138
- Scott Topper · Broad Institute, Inc.$51,811,587
Research focus
DiagnosticSamplingLeadPhenotypeResponseDevicesCellsBlood PlateletsPlatelet AggregationClinical PracticeHemorrhageBlood Coagulation DisordersPlatelet FunctionMeasurementBaseLifeCostResearch Clinical TestingSymptomsPhysiciansPediatric PatientsDiagnosisInnovationBasic Science
Grant awards (21)
Form with function: Rapid phenotypic carbapenemase testing to improve detection of carbapenemase-producing organisms$3,055,197
R01 · FY2025 · AI · contact PI
Integrating low-cost and versatile technologies to achieve colorimetric HCV and HIV detection from whole blood$720,805
R01 · FY2025 · AI · contact PI
iPPSIS: implanted Passive Pressure Sensor Interrogated with (ultra)-Sound$523,481
R01 · FY2025 · EB · contact PI
Leveraging platelet contraction cytometry for immune thrombocytopenia$384,010
R01 · FY2025 · HL · contact PI
Advancement of Diagnostics by Joining User-centered and Scalable Technologies - Training Program (ADJUST TP)$108,384
T32 · FY2025 · EB
Integrating low-cost and versatile technologies to achieve colorimetric HCV and HIV detection from whole blood$680,721
R01 · FY2024 · AI
iPPSIS: implanted Passive Pressure Sensor Interrogated with (ultra)-Sound$495,977
R01 · FY2024 · EB · contact PI
Leveraging platelet contraction cytometry for immune thrombocytopenia$384,555
R01 · FY2024 · HL · contact PI
Leveraging platelet contraction cytometry for immune thrombocytopenia$385,050
R01 · FY2023 · HL · contact PI
Wearable Microchip for Assessing Global Hemostatsis$157,549
K25 · FY2023 · HL · contact PI
Leveraging platelet contraction cytometry for immune thrombocytopenia$385,499
R01 · FY2022 · HL · contact PI
Wearable Microchip for Assessing Global Hemostatsis$157,549
K25 · FY2022 · HL · contact PI
iPPSIS: implanted Passive Pressure Sensor Interrogated with (ultra)-Sound$450,081
R21 · FY2021 · EB · contact PI
Leveraging platelet contraction cytometry for immune thrombocytopenia$385,909
R01 · FY2021 · HL · contact PI
Wearable Microchip for Assessing Global Hemostatsis$157,549
K25 · FY2021 · HL · contact PI
Platelet contraction cytometry as a novel assay of platelet function$234,000
R21 · FY2020 · EB · contact PI
Wearable Microchip for Assessing Global Hemostatsis$157,549
K25 · FY2020 · HL · contact PI
Platelet contraction cytometry as a novel assay of platelet function$68,879
R21 · FY2020 · EB · contact PI
Platelet contraction cytometry as a novel assay of platelet function$195,000
R21 · FY2019 · EB · contact PI
Wearable Microchip for Assessing Global Hemostatsis$157,549
K25 · FY2019 · HL · contact PI
Platelet contraction cytometry as a novel assay of platelet function$195,000
R21 · FY2018 · EB · contact PI